(3R,5S,8R,9S,10S,13S,14S)-3-hydroxy-3-[[4-[(2-methoxy-4-methyl-phenyl)methyl]piperazin-1-yl]methyl]-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-one

ID: ALA4642468

PubChem CID: 156016677

Max Phase: Preclinical

Molecular Formula: C33H50N2O3

Molecular Weight: 522.77

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1cc(C)ccc1CN1CCN(C[C@@]2(O)CC[C@@]3(C)[C@@H](CC[C@@H]4[C@@H]3CC[C@]3(C)C(=O)CC[C@@H]43)C2)CC1

Standard InChI:  InChI=1S/C33H50N2O3/c1-23-5-6-24(29(19-23)38-4)21-34-15-17-35(18-16-34)22-33(37)14-13-31(2)25(20-33)7-8-26-27-9-10-30(36)32(27,3)12-11-28(26)31/h5-6,19,25-28,37H,7-18,20-22H2,1-4H3/t25-,26-,27-,28-,31-,32-,33+/m0/s1

Standard InChI Key:  JDHQLVHWJRAJEX-ZJHSDCFHSA-N

Molfile:  

 
     RDKit          2D

 42 47  0  0  0  0  0  0  0  0999 V2000
    7.1985  -14.3332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9114  -13.9229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6242  -14.3332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6242  -15.1583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9114  -15.5729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1985  -15.1583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3710  -15.1583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9603  -15.8714    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3710  -16.5887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9603  -17.3018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1350  -17.3018    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7203  -16.5887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1350  -15.8714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7203  -18.0150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8949  -18.0150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4839  -18.7281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6621  -18.7312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2472  -18.0135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6571  -17.3044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4817  -17.2975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4219  -18.0135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8946  -19.4455    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7199  -19.4455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7826  -15.8749    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.3371  -15.5729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0541  -15.1583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0541  -14.3333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3371  -13.9229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3371  -13.0978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0542  -12.6832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7671  -13.0979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7670  -13.9229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5509  -14.1790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0357  -13.5085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5510  -12.8419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7646  -12.0484    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.7670  -14.7483    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   10.7671  -12.2725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3371  -14.7482    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   10.0541  -13.5079    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    8.6242  -15.9836    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    8.6242  -13.5079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  6  5  1  0
  1  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  8 13  1  0
 11 14  1  0
 14 15  1  0
 16 15  2  0
 17 16  1  0
 18 17  2  0
 19 18  1  0
 20 19  2  0
 15 20  1  0
 18 21  1  0
 16 22  1  0
 22 23  1  0
  6 24  1  6
  4 25  1  0
 26 25  1  0
 27 26  1  0
 28 27  1  0
  3 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 27 32  1  0
 32 33  1  0
 34 33  1  0
 35 34  1  0
 31 35  1  0
 35 36  2  0
 32 37  1  6
 31 38  1  1
 28 39  1  6
 27 40  1  1
  4 41  1  6
  3 42  1  1
M  END

Alternative Forms

  1. Parent:

    ALA4642468

    ---

Associated Targets(Human)

LAPC4 (305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 522.77Molecular Weight (Monoisotopic): 522.3821AlogP: 5.46#Rotatable Bonds: 5
Polar Surface Area: 53.01Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.23CX LogP: 5.64CX LogD: 4.75
Aromatic Rings: 1Heavy Atoms: 38QED Weighted: 0.56Np Likeness Score: 0.87

References

1. Boutin S, Roy J, Maltais R, Poirier D..  (2020)  Formation of 5α-dihydrotestosterone from 5α-androstane-3α,17β-diol in prostate cancer LAPC-4 cells - Identifying inhibitors of non-classical pathways producing the most potent androgen.,  30  (2): [PMID:31753699] [10.1016/j.bmcl.2019.126783]
2. Boutin S,Maltais R,Roy J,Poirier D.  (2021)  Synthesis of 17β-hydroxysteroid dehydrogenase type 10 steroidal inhibitors: Selectivity, metabolic stability and enhanced potency.,  209  [PMID:33081987] [10.1016/j.ejmech.2020.112909]

Source